Viewing Study NCT05524857


Ignite Creation Date: 2025-12-24 @ 7:08 PM
Ignite Modification Date: 2026-02-08 @ 12:02 PM
Study NCT ID: NCT05524857
Status: TERMINATED
Last Update Posted: 2024-04-23
First Post: 2022-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP)
Sponsor: Joseph Jurcic
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: AAAT9407
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View